# Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC

> **NCT06681688** · PHASE1,PHASE2 · RECRUITING · sponsor: **Inder Paul Singh, M.D.** · enrollment: 94 (estimated)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Omidria, {0.3%-1% Intraocular Solution}, VIGAMOX {0.5% moxifloxacin hydrochloride}, Kenalog {0.4 ml, 10mg/ml, triamcinolone acetonide}
- **DRUG:** Ketorolac (0.5%) {Toradol}, moxifloxacin (0.5%) {VIGAMOX}, prednisolone acetate (1%) {Pred Forte}

## Key facts

- **NCT ID:** NCT06681688
- **Lead sponsor:** Inder Paul Singh, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-06
- **Final completion:** 2025-08
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681688, "Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06681688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*